Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Adienne Pharma & Biotech SA has 3 pending office actions in Medical Devices & Mechanical Engineering. The matters involve 3 distinct examiners and 3 distinct art units, with each matter appearing in a separate examination context.
BOSWORTH, KAMI A is the busiest examiner, with 1 pending matter. The data points to application-specific prosecution planning rather than a shared examiner strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOSWORTH, KAMI A | 1 | 69.1% | +28.6% |
| DEL PRIORE, ALESSANDRO R | 1 | 62.0% | +44.1% |
| BARSKY, JARED | 1 | 50.3% | +22.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19222541 | MULTI CHAMBER FLEXIBLE BAG AND METHODS OF USING SAME | BOSWORTH, KAMI A | — |
| 18746743 | TREATMENT OF PRIMARY CTLA-4 CHECKPOINT RELATED IMMUNODEFICIENCIES | BARSKY, JARED | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19222541 | MULTI CHAMBER FLEXIBLE BAG AND METHODS OF USING SAME | BOSWORTH, KAMI A | — |
| 18893588 | STERILE OR STERILIZED PACKAGE FOR ADMINISTRATION OF MEDICINAL OR NUTRITIONAL SUBSTANCES | DEL PRIORE, ALESSANDRO R | — |
| 18746743 | TREATMENT OF PRIMARY CTLA-4 CHECKPOINT RELATED IMMUNODEFICIENCIES | BARSKY, JARED | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| 3781 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19222541 | MULTI CHAMBER FLEXIBLE BAG AND METHODS OF USING SAME | BOSWORTH, KAMI A | 3783 | §102§103§112 | Non-Final OA | — | Pending | May 29, 2025 |
| 18893588 | STERILE OR STERILIZED PACKAGE FOR ADMINISTRATION OF MEDICINAL OR NUTRITIONAL SUBSTANCES | DEL PRIORE, ALESSANDRO R | 3781 | §103DP | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18746743 | TREATMENT OF PRIMARY CTLA-4 CHECKPOINT RELATED IMMUNODEFICIENCIES | BARSKY, JARED | 1628 | §101§102§103§112DP | Non-Final OA | — | Pending | Jun 18, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAdienne Pharma & Biotech SA has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Kami A Bosworth has the most, with 1 of Adienne Pharma & Biotech SA's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
